Entest BioMedical Entering Veterinary Market
September 22, 2010
Entest BioMedical Inc. plans to get its immunotherapeutic cancer vaccine for dogs, ImenVax, on the market within 12 months, the La Mesa, Calif., company said Tuesday during a blogcast. The vaccine would mark Entest BioMedical’s entry into the veterinary market. One out of three to four dogs will develop cancer and 50 percent of dogs… Continue reading...